Ginsenoside Rb1 reverses H 2O 2-induced senescence in human umbilical endothelial cells: Involvement of eNOS pathway

Journal of Cardiovascular Pharmacology

Volumn 59, Issue 3, 2012, Pages 222-230

  Liu, Ding Hui ^a   Chen, Yan Ming ^a   Liu, Yong ^a   Hao, Bao Shun ^a   Zhou, Bin ^a   Wu, Lin ^a   Wang, Min ^a   Chen, Lin ^a   Wu, Wei Kang ^a   Qian, Xiao Xian ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

endothelial nitric oxide synthase; ginsenoside Rb1; HUVEC; senescence

Indexed keywords

BETA GALACTOSIDASE; CAVEOLIN 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GINSENOSIDE RB 1; HYDROGEN PEROXIDE; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRATE REDUCTASE; NITRIC OXIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE B; SENESCENCE ASSOCIATED BETA GALACTOSIDASE; UNCLASSIFIED DRUG;

ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SENESCENCE; WESTERN BLOTTING;

BETA-GALACTOSIDASE; BLOTTING, WESTERN; CELL AGING; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GINSENOSIDES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYDROGEN PEROXIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84858794576     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31823c1d34     Document Type: Article

References (50)

1. Collado M, Blasco MA, Serrano M. Cell senescence in cancer and aging. Cell. 2007;130:223-233.
2. Minamino T, Miyauci H, Yoshida T, et al. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation. 2002;105:1541-1544. (Pubitemid 34297628)
3. Karlseder J, Smogorzewska A, de Lange T. Senescence induced by altered telomere state, not telomere loss. Science. 2002;295:2446-2449. (Pubitemid 34270257)
4. Cheng Y, Shen L, Zhang J. Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action. Acta Pharmacol Sin. 2005;26:143-149. (Pubitemid 40203956)
5. Ohashi R, Yan S, Mu H, et al. Effects of homocysteine and ginsenoside Rb1 on endothelial cell line proliferation and superoxide anion production. J Surg Res. 2006;133:89-94.
6. Zhou W, Chai H, Lin PH, et al. Ginsenoside Rb1 blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries. J Vasc Surg. 2005;41:861-868. (Pubitemid 40693810)
7. Schmitt CA, Dirsch VM. Modulation of endothelial nitric oxide by plant-derived products. Nitric Oxide. 2009;21:77-91.
8. Bandin B, Bruneel A, Bosselut N, et al. A protocol for isolation and culture of human umbilical vein endothelial cells. Nat Protoc. 2007;2: 481-485. (Pubitemid 47040010)
9. Dimri GP, Lee X, Basile G, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA. 1995;92:9363-9367.
10. Madamanchi NR, Vendrov A, Runge MS. Oxidative stress and vascular disease. Arteroiscler Thromb Vasc Biol. 2005;25:29-38. (Pubitemid 40054251)
11. Seals DR, Moreau KL, Gates PE, et al. Modulatory influences on ageing of the vasculature in healthy humans. Exp Gerontol. 2006;41:501-507. (Pubitemid 43765901)
12. Hamilton CA, Brosnan MJ, Mclntyre M, et al. Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction. Hypertension. 2001;37:529-534. (Pubitemid 32199023)
13. Francia P, delli Gatti C, Bachschmid M, et al. Deletion of p66shc gene protects against age-related endothelial dysfunction. Circulation. 2004; 110:2889-2895. (Pubitemid 39473614)
14. Taddei S, Virdis A, Ghiadoni L, et al. Age-related reduction of NO availability and oxidative stress in human. Hypertension. 2001;38:274-279. (Pubitemid 34224757)
15. Donato AJ, Eskurza I, Silver AE, et al. Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium- dependent dilation and upregulation of nuclear factor-kB. Circ Res. 2007;100:1659-1666. (Pubitemid 46897269)
16. + depletion. Cell Physiol Biochem. 2007;20: 45-54. (Pubitemid 46956811)
17. 2 induced cellular senescence. Biol Pharm Bull. 2008;31:1265-1269. (Pubitemid 351876706)
18. Oeseburg H, Insuf D, van der Harst P, et al. Bradykinin protects against oxidative stress induced endothelial cell senescence. Hypertension. 2009; 53(pt 2):1-6.
19. Aoyagi M, Arvai AS, Tainer JA, et al. Structural basis for endothelial nitric oxide synthase binding to calmodulin. EMBO J. 2003;22: 766-775. (Pubitemid 36227779)
20. Matsushita H, Chang E, Glassford AJ, et al. eNOS activity is reduced in senescent human endothelial cells. Preservation by hTERT immortalization. Circ Res. 2001;89:793-798. (Pubitemid 34633850)
21. Sato I, Morita I, Kaji K, et al. Reduction of nitric oxide producing activity associated with in vitro aging in cultured human umbilical vein endothelial cell. Biochem Biophys Res Commun. 1993;195: 1070-1076. (Pubitemid 23280524)
22. Ota H, Akishita M, Eto M, et al. SIRT1 modulates premature senescencelike phenotype in human endothelial cells. J Mol Cell Cardiol. 2007;43: 571-579. (Pubitemid 47615048)
23. Cai H, Davis ME, Drummond GR, et al. Induction of endothelial NO synthase by hydrogen peroxide via a Ca2+/calmodulin-denpendent protein kinase II/janus kinase 2-dependent pathway. Arterioscler Thromb Vasc Biol. 2001;21:1571-1576. (Pubitemid 34215574)
24. Cai H, Li Z, Davis ME, et al. Akt-dependent phosphorylation of serine 1179 and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase 1/2 cooperatively mediate activation of the endothelial nitric-oxide synthase by hydrogen peroxide. Mol Pharmacol. 2003;63: 325-331. (Pubitemid 36158367)
25. Drummond GR, Cai H, Davis ME, et al. Transcriptional and posttran-scriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circ Res. 2000;86:347-354. (Pubitemid 30108830)
26. Thomas SR, Chen K, Keaney JF, Jr. Hydrogen peroxide activates endo-thelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway. J Biol Chem. 2002;277:6017-6024. (Pubitemid 34968385)
27. Wedgwood S, Black SM. Endothelin-1 decrease endothelial NOS expression and activity through ETA receptor-mediated generation of hydrogen peroxide. Am J Physiol Lung Cell Mol Physiol. 2005;288: 480-487.
28. Kumar S, Sun X, Wedgwood S, et al. Hydrogen peroxide decreases endothelial nitric oxide synthase promoter activity through the inhibition of AP-1 activity. Am J Physiol Lung Cell Mol Physiol. 2008;295: 370-377.
29. Kumar S, Sun X, Wiseman DA, et al. Hydrogen peroxide decreases endothelial nitric oxide synthase promoter activity through the inhibition of Sp1 activity. DNA Cell Biol. 2009;28:119-129.
30. Álvarez-Maqueda M, Beka RE, Monteseirín J, et al. Homocysteine enhances superoxide anion release and NADPH oxidase assembly by human neutrophils. Effects on MAPK activation and neutrophil migration. Atherosclerosis. 2004;172:229-238. (Pubitemid 38167533)
31. Yoon HJ, Cho SW, Ahn BW, et al. Alterations in the activity and expression of endothelial NO synthase in aged human endothelial cells. Mech Ageing Dev. 2010;131:119-123.
32. Yokoi T, Fukuo K, Yasuda O, et al. Apoptosis signal-regulating kinase 1 mediate cellular senescence induced by high glucose in endothelial cells. Diabetes. 2006;55:1660-1665. (Pubitemid 44324118)
33. Bernhard D, Wang XL. Smoking, oxidative stress and cardiovascular diseases-do anti-oxidative therapies fail? Curr Med Chem. 2007;14: 1703-1712. (Pubitemid 47163408)
34. Durante W, Johnson FK, Johnson RA. Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Phys-iol. 2007;34:906-911. (Pubitemid 47083958)
35. Yang YM, Huang A, Kaley G, et al. eNOS uncoupling and endothelial dysfunction in aged vessels. Am JPhysiolHeart Circ Physiol. 2009;297: 1829-1836.
36. Zou MH, Cohen R, Ullrich V. Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus. Endothelium. 2004;11:89-97. (Pubitemid 39207182)
37. Zou MH, Shi C, Cohen RA. Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest. 2002;109:817-826. (Pubitemid 34263158)
38. Jankowski J, van der Giet M, Jankowski V, et al. Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression. J Clin Invest. 2003;112:256-264. (Pubitemid 38056361)
39. Ali AK, Banks WA, Kumar VB, et al. Nitric oxide activity and isoenzyme expression in the senescence-accelerated mouse P8 model of Alzheimer's disease-effects of anti-amyloid antibody and antisense treatments. J Ger-ontol A Biol Sci Med Sci. 2009;64:1025-1030.
40. Pojoga LH, Yao TM, Sinha S, et al. Effect of dietary sodium on vasocon-striction and eNOS-mediated vascular relaxation in caveolin-1-deficient mice. Am J Physiol Heart Circ Physiol. 2008;294:1258-1265.
41. Maniatis NA, Brovkovych V, Allen SE, et al. Novel mechanism of endothelial nitric oxide synthase activation mediated by caveolae inter-nalization in endothelial cells. Circ Res. 2006;99:870-877. (Pubitemid 44556386)
42. Zhao YY, Zhao YD, Mirza MK, et al. Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration. J Clin Invest. 2009;119: 2009-2018.
43. Khan EM, Heidinger JM, Levy M, et al. Epidermal growth factor receptor exposed to oxidative stress undergoes Src-and caveolin-1-dependent perinuclear trafficking. J Biol Chem. 2006;281: 14486-14493. (Pubitemid 43848379)
44. Dai SM, Shan ZZ, Nakamura H, et al. Catabolic stress induces features of chondrocyte senescence through overexpression of caveolin-1. Possible involvement of caveolin-1-induced down-regulation of articular chondrocytes in the pathogenesis of osteoarthritis. Arthritis Rheum. 2006;54:818-831.
45. Voghel G, Thorin-Trescases N, Farhat N, et al. Cellular senescence in endothelial cells from atherosclerotic patients is accelerated by oxidative stress associated with cardiovascular risk factors. Mech Ageing Dev. 2007;128:662-671. (Pubitemid 350299049)
46. Nogueira V, Park Y, Chen CC, et al. Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell. 2008;14:458-470.
47. Levine YC, Li GK, Michel T. Agonist-modulated regulation of AMP-activated protein kinase (AMPK) in endothelial cells. Evidence for an AMPK-Rac1-Akt-endothelial nitric oxide synthase pathway. J Biol Chem. 2007;283:20351-20364. (Pubitemid 47100039)
48. Murata T, Kinoshita K, Hori M, et al. Statin protects endothelial nitric oxide synthase activity in hypoxia-induced pulmonary hypertension. Arterioscler Thromb Vasc Biol. 2005;25:2335-2342. (Pubitemid 41552651)
49. Cokic VP, Beleslin-Cokic BB, Tomic M, et al. Hydroxyurea induces the eNOS-cGMP pathway in endothelial cells. Blood. 2006;108: 184-191. (Pubitemid 43990627)
50. Osuka K, Watanabe Y, Usuda N, et al. Modification of endothelial nitric oxide synthase through AMPK after experimental subarachnoid hemorrhage. J Neurotrauma. 2009;26:1157-1165.